Literature DB >> 24778349

Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.

R A Hälg1, J Besserer, M Boschung, S Mayer, A J Lomax, U Schneider.   

Abstract

In radiation therapy, high energy photon and proton beams cause the production of secondary neutrons. This leads to an unwanted dose contribution, which can be considerable for tissues outside of the target volume regarding the long term health of cancer patients. Due to the high biological effectiveness of neutrons in regards to cancer induction, small neutron doses can be important. This study quantified the neutron doses for different radiation therapy modalities. Most of the reports in the literature used neutron dose measurements free in air or on the surface of phantoms to estimate the amount of neutron dose to the patient. In this study, dose measurements were performed in terms of neutron dose equivalent inside an anthropomorphic phantom. The neutron dose equivalent was determined using track etch detectors as a function of the distance to the isocenter, as well as for radiation sensitive organs. The dose distributions were compared with respect to treatment techniques (3D-conformal, volumetric modulated arc therapy and intensity-modulated radiation therapy for photons; spot scanning and passive scattering for protons), therapy machines (Varian, Elekta and Siemens linear accelerators) and radiation quality (photons and protons). The neutron dose equivalent varied between 0.002 and 3 mSv per treatment gray over all measurements. Only small differences were found when comparing treatment techniques, but substantial differences were observed between the linear accelerator models. The neutron dose equivalent for proton therapy was higher than for photons in general and in particular for double-scattered protons. The overall neutron dose equivalent measured in this study was an order of magnitude lower than the stray dose of a treatment using 6 MV photons, suggesting that the contribution of the secondary neutron dose equivalent to the integral dose of a radiotherapy patient is small.

Entities:  

Mesh:

Year:  2014        PMID: 24778349     DOI: 10.1088/0031-9155/59/10/2457

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  13 in total

1.  Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.

Authors:  Damien C Weber; Shahed Badiyan; Robert Malyapa; Francesca Albertini; Alessandra Bolsi; Antony J Lomax; Ralf Schneider
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

Review 2.  Neutron dose and its measurement in proton therapy-current State of Knowledge.

Authors:  Roger Antoine Hälg; Uwe Schneider
Journal:  Br J Radiol       Date:  2020-01-21       Impact factor: 3.039

Review 3.  Myths and realities of range uncertainty.

Authors:  Antony John Lomax
Journal:  Br J Radiol       Date:  2019-12-23       Impact factor: 3.039

4.  Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.

Authors:  Marijke De Saint-Hubert; Nico Verbeek; Christian Bäumer; Johannes Esser; Jörg Wulff; Racell Nabha; Olivier Van Hoey; Jérémie Dabin; Florian Stuckmann; Fabiano Vasi; Stephan Radonic; Guillaume Boissonnat; Uwe Schneider; Miguel Rodriguez; Beate Timmermann; Isabelle Thierry-Chef; Lorenzo Brualla
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

5.  Clinical and Radiologic Outcomes in Adults and Children Treated with Pencil-Beam Scanning Proton Therapy for Low-Grade Glioma.

Authors:  Shahed N Badiyan; Stephan Ulmer; Frank J Ahlhelm; Anna S M Fredh; Ulrike Kliebsch; Gabriele Calaminus; Alessandra Bolsi; Francesca Albertini; Dominic Leiser; Beate Timmermann; Robert S Malyapa; Ralf Schneider; Antony J Lomax; Damien C Weber
Journal:  Int J Part Ther       Date:  2017-07-11

6.  Modelling and measurements of distributions in an adult human phantom undergoing proton scanning beam radiotherapy: lung- and prostate-located tumours.

Authors:  Monika Puchalska
Journal:  Radiat Environ Biophys       Date:  2021-03-02       Impact factor: 1.925

7.  Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.

Authors:  Allison Toltz; Naomi Shin; Ellis Mitrou; Cecile Laude; Carolyn R Freeman; Jan Seuntjens; William Parker; David Roberge
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

8.  Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.

Authors:  Bruno A Speleers; Francesca M Belosi; Werner R De Gersem; Pieter R Deseyne; Leen M Paelinck; Alessandra Bolsi; Antony J Lomax; Bert G Boute; Annick E Van Greveling; Christel M Monten; Joris J Van de Velde; Tom H Vercauteren; Liv Veldeman; Damien C Weber; Wilfried C De Neve
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 9.  The Impact of Neutrons in Clinical Proton Therapy.

Authors:  Uwe Schneider; Roger Hälg
Journal:  Front Oncol       Date:  2015-10-21       Impact factor: 6.244

10.  Design and fabrication of a Nano-based neutron shield for fast neutrons from medical linear accelerators in radiation therapy.

Authors:  Younes Afkham; Asghar Mesbahi; Abdolali Alemi; Farhad Zolfagharpour; Nasrollah Jabbari
Journal:  Radiat Oncol       Date:  2020-05-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.